H

Hillel Yaffe Medical Center | Neurology Department

Research site
(Unclaimed)
Location
1 Ha-Shalom Way, Hadera, HaTsafon, Israel
Site insights

Top conditions

Hypercholesterolemia (2 trials)

Hyperlipoproteinemia Type II (1 trial)

Arteriosclerosis (1 trial)

Top treatments

MK-0616

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of MK-0616 (Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The primary...

Enrolling
Hypercholesterolemia
Familial Hypercholesterolemia
Drug: MK-0616
Drug: Placebo

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of MK-0616, an oral proprotein convertase subtilisin/kexin type 9...

Enrolling
Arteriosclerosis
Hypercholesterolaemia
Drug: Placebo
Drug: MK-0616

Trial sponsors

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD) (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems